BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23814582)

  • 1. Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children.
    Rebuffini E; Zuccarino L; Grecchi E; Carinci F; Merulla VE
    Dent Res J (Isfahan); 2012 Dec; 9(Suppl 2):S192-6. PubMed ID: 23814582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective - A retrospective case series.
    Fasching G; Dollinger C; Spendel S; Tepeneu NF
    Ann Med Surg (Lond); 2022 Sep; 81():104531. PubMed ID: 36147081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OK-432 (Picibanil) therapy for lymphangiomas in children.
    Laranne J; Keski-Nisula L; Rautio R; Rautiainen M; Airaksinen M
    Eur Arch Otorhinolaryngol; 2002 May; 259(5):274-8. PubMed ID: 12107533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lymphangiomas with OK-432 (Picibanil).
    Rautio R; Keski-Nisula L; Laranne J; Laasonen E
    Cardiovasc Intervent Radiol; 2003; 26(1):31-6. PubMed ID: 12491020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.
    Greinwald JH; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM; Smith RJ
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):381-7. PubMed ID: 10504592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OK-432 therapy for cervical lymphangioma.
    Sichel JY; Udassin R; Gozal D; Koplewitz BZ; Dano I; Eliashar R
    Laryngoscope; 2004 Oct; 114(10):1805-9. PubMed ID: 15454776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picibanil).
    Brewis C; Pracy JP; Albert DM
    Clin Otolaryngol Allied Sci; 2000 Apr; 25(2):130-4. PubMed ID: 10816217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-center experience in the management of head and neck lymphangiomas.
    Aluffi Valletti P; Brucoli M; Boffano P; Benech A; Toso A; Dell'Era V; Garzaro M
    Oral Maxillofac Surg; 2020 Mar; 24(1):109-115. PubMed ID: 31960163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OK-432 therapy for cervicofacial lymphangioma in adults].
    Peral Cagigal B; Serrat Soto A; Calero H; Verrier Hernández A
    Acta Otorrinolaringol Esp; 2007 May; 58(5):222-4. PubMed ID: 17498476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OK-432 therapy for lymphangiomas.
    Smith RJ; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM
    Arch Otolaryngol Head Neck Surg; 1996 Nov; 122(11):1195-9. PubMed ID: 8906054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
    Giguère CM; Bauman NM; Sato Y; Burke DK; Greinwald JH; Pransky S; Kelley P; Georgeson K; Smith RJ
    Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1137-44. PubMed ID: 12365884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OK-432 therapy of lymphangiomas in children.
    Schmidt B; Schimpl G; Höllwarth ME
    Eur J Pediatr; 1996 Aug; 155(8):649-52. PubMed ID: 8839717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OK-432: an effective sclerosing agent for the treatment of lymphangiomas of head and neck.
    Baskota DK; Singh BB; Sinha BK
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):312-7. PubMed ID: 18604046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis.
    Sun J; Wang C; Song D; Wu C; Guo L
    Braz J Otorhinolaryngol; 2023; 89(4):101270. PubMed ID: 37331237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children?
    Hall N; Ade-Ajayi N; Brewis C; Roebuck DJ; Kiely EM; Drake DP; Spitz L; Pierro A
    Surgery; 2003 Mar; 133(3):238-42. PubMed ID: 12660633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations: long-term follow-up results.
    Weitz-Tuoretmaa A; Rautio R; Valkila J; Keski-Säntti H; Keski-Nisula L; Laranne J
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):385-90. PubMed ID: 23649509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy of cervical cysts with Picibanil (OK-432).
    Knipping S; Goetze G; Neumann K; Bloching M
    Eur Arch Otorhinolaryngol; 2007 Apr; 264(4):423-7. PubMed ID: 17082941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional Injection of OK-432 in Cystic Hygroma.
    Hazim M; Moses SS; Tan IP
    Med J Malaysia; 2016 Dec; 71(6):328-330. PubMed ID: 28087956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [OK-432 therapy for lymphangioma in children].
    Ruiz E; Valera ET; Veríssimo F; Tone LG
    J Pediatr (Rio J); 2004; 80(2):154-8. PubMed ID: 15079187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OK-432 therapy for unresectable lymphangiomas in children.
    Ogita S; Tsuto T; Deguchi E; Tokiwa K; Nagashima M; Iwai N
    J Pediatr Surg; 1991 Mar; 26(3):263-8; discussion 268-70. PubMed ID: 2030471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.